NASDAQ : ANIP

ANI Pharmaceuticals, Inc. — Financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 72 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.54B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

ANI Pharmaceuticals, Inc. (ANIP) reported revenue of 978.38M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue978.38M883.37M614.38M486.82M316.38M216.14M
Cost of Revenue387.40M341.31M236.61M181.51M138.78M100.61M
Gross Profit590.98M542.06M377.77M305.30M177.60M115.53M
Selling, General & Admin331.66M315.64M231.54M161.70M124.04M84.29M
Research & Development49.91M51.66M44.58M34.29M22.32M11.37M
Other Operating Expenses780.00K
Operating Expenses467.38M458.73M343.85M255.77M203.33M143.69M
Operating Income123.60M83.33M33.92M49.53M-25.73M-28.17M
Interest Expense-30.90M-32.18M-33.14M-35.05M-28.42M-11.95M
Interest & Investment Income14.36M12.12M15.53M8.11M366.00K23.00K
Currency Exchange Gain (Loss)-1.12M1.93M
Other Non Operating Income (Expenses)-4.03M-159.00K670.00K-4.71M
EBT Excluding Unusual Items105.94M65.20M12.28M22.43M-53.12M-44.80M
Merger & Restructuring Charges-2.10M-2.10M-31.70M-1.13M-5.68M
Gain (Loss) on Sale of Investments9.91M2.82M6.31M
Gain (Loss) on Sale of Assets-382.00K-382.00K5.35M1.82M
Asset Writedown-767.00K-767.00K-7.60M-112.00K-2.37M
Legal Settlements9.00M-8.75M
Other Unusual Items21.00M31.01M-6.85M-1.43M-3.76M-1.96M
Pretax Income142.60M95.79M-22.21M19.87M-62.66M-56.06M
Income Tax Expense34.29M17.45M-3.69M1.09M-14.77M-13.46M
Net Income108.31M78.34M-18.52M18.78M-47.90M-42.60M
Preferred Dividends & Other Adjustments8.71M8.12M1.62M3.30M1.62M190.00K
Net Income to Common99.60M70.22M-20.15M15.47M-49.52M-42.79M
Shares Outstanding (Basic)20.71M20.05M19.32M18.00M16.26M12.60M
Shares Outstanding (Diluted)22.03M21.23M19.32M18.19M16.26M12.60M
EPS (Basic)4.813.50-1.040.86-3.05-3.40
EPS (Diluted)4.543.32-1.040.85-3.05-3.40
Free Cash Flow172.99M171.39M47.78M110.09M-40.08M765.00K
Free Cash Flow Per Share7.858.072.476.05-2.460.06
Gross Margin60.40%61.36%61.49%62.71%56.13%53.45%
Operating Margin12.63%9.43%5.52%10.17%-8.13%-13.03%
Profit Margin10.18%7.95%-3.28%3.18%-15.65%-19.80%
Free Cash Flow Margin17.68%19.40%7.78%22.61%-12.67%0.35%
EBITDA209.41M174.75M101.65M109.32M33.92M19.08M
EBITDA Margin21.40%19.78%16.55%22.46%10.72%8.83%
D&A For EBITDA85.80M91.42M67.73M59.79M59.65M47.25M
EBIT123.60M83.33M33.92M49.53M-25.73M-28.17M
EBIT Margin12.63%9.43%5.52%10.17%-8.13%-13.03%
Effective Tax Rate24.04%18.22%5.50%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents360.21M285.58M144.86M221.12M48.23M100.30M
Short-Term Investments15.63M9.13M6.31M
Cash & Short-Term Investments376.96M294.72M151.17M221.12M48.23M100.30M
Receivables274.47M281.08M221.73M162.08M165.44M128.53M
Inventory143.15M143.07M136.78M111.20M105.36M81.69M
Prepaid Expenses30.62M22.99M17.98M17.40M8.39M7.59M
Restricted Cash35.00K36.00K33.00K5.01M
Other Current Assets200.00K11.23M772.00K8.02M11.85M3.67M
Total Current Assets825.43M753.12M528.46M519.82M344.26M321.77M
Property, Plant & Equipment73.22M62.48M56.86M44.59M43.25M52.67M
Long-Term Investments1.65M4.90M6.24M8.80M
Goodwill62.48M62.48M59.99M28.22M28.22M27.89M
Other Intangible Assets449.86M479.53M541.83M209.01M251.63M294.12M
Long-Term Deferred Tax Assets71.50M69.07M85.11M90.71M81.36M67.94M
Long-Term Deferred Charges500.00K600.00K
Other Long-Term Assets11.12M11.46M7.32M5.84M2.56M7.21M
Total Assets1.49B1.44B1.28B904.42M760.09M771.60M
Accounts Payable73.83M62.58M45.66M36.68M29.30M22.97M
Accrued Expenses140.95M144.32M92.80M57.84M35.88M27.89M
Current Portion of Long-Term Debt21.33M17.27M9.17M850.00K850.00K850.00K
Current Portion of Leases2.03M
Current Income Taxes Payable3.53M2.24M7.52M8.16M
Other Current Liabilities44.01M49.67M39.30M41.94M33.40M35.83M
Total Current Liabilities283.65M278.11M194.45M145.48M99.44M87.54M
Long-Term Debt589.16M599.77M614.92M284.82M285.67M286.52M
Long-Term Leases15.54M9.22M1.38M
Other Long-Term Liabilities8.55M12.55M46.57M16.53M35.06M38.80M
Total Liabilities896.90M899.65M855.94M446.82M421.55M412.86M
Common Stock3.00K3.00K2.00K2.00K1.00K1.00K
Additional Paid-In Capital620.25M596.04M519.65M514.10M403.90M387.84M
Retained Earnings31.10M-23.10M-100.28M-80.13M-97.29M-47.77M
Treasury Stock-53.82M-33.25M-21.04M-10.08M-5.09M-3.13M
Comprehensive Income & Other-327.00K1.03M5.34M8.86M12.17M-3.06M
Total Common Equity597.21M540.72M403.68M432.75M313.69M333.89M
Shareholders' Equity597.21M540.72M428.53M457.60M338.54M358.74M
Total Liabilities & Equity1.49B1.44B1.28B904.42M760.09M771.60M
Total Debt626.03M628.28M624.09M285.67M287.90M287.37M
Net Cash (Debt)-249.07M-333.57M-472.92M-64.55M-239.67M-187.07M
Net Cash Per Share-11.30-15.71-24.48-3.55-14.74-14.85
Filing Date Shares Outstanding21.43M20.88M20.31M19.72M16.35M16.55M
Total Common Shares Outstanding21.43M20.95M19.65M19.12M16.35M16.12M
Working Capital541.78M475.00M334.00M374.34M244.82M234.24M
Book Value Per Share27.8725.8020.5422.6419.1820.71
Tangible Book Value84.88M-1.28M-198.14M195.52M33.83M11.88M
Tangible Book Value Per Share3.96-0.06-10.0810.232.070.74
Land2.41M1.58M1.55M1.55M5.95M
Buildings25.83M24.44M17.88M16.66M19.97M
Machinery76.04M68.70M50.41M53.15M46.77M
Construction In Progress8.82M4.57M7.69M4.60M2.94M
Leasehold Improvements1.41M1.30M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income108.31M78.34M-18.52M18.78M-47.90M-42.60M
Depreciation & Amortization85.80M91.42M67.73M59.79M59.65M47.25M
Loss (Gain) From Sale of Assets382.00K382.00K-5.35M-750.00K-1.82M
Asset Writedown & Restructuring Costs767.00K767.00K7.60M1.73M2.37M
Loss (Gain) From Sale of Investments-9.91M-2.82M-6.31M
Stock-Based Compensation41.06M37.93M29.34M20.65M14.60M10.49M
Other Operating Activities960.00K-13.66M703.00K-5.12M-7.23M-12.28M
Change in Accounts Receivable-48.37M-58.53M-21.09M3.36M-36.91M-5.55M
Change in Inventory-4.56M-5.96M-21.29M-5.84M-23.63M3.22M
Change in Accounts Payable10.77M15.16M479.00K7.55M5.04M10.17M
Change in Income Taxes241.00K-15.53M-1.42M11.99M-160.00K-7.57M
Change in Other Net Operating Assets4.01M57.74M32.12M7.80M4.36M-353.00K
Operating Cash Flow189.47M185.22M64.02M118.96M-31.20M3.32M
Capital Expenditures-16.48M-13.84M-16.24M-8.87M-8.88M-2.56M
Sale of Property, Plant & Equipment13.51M750.00K2.65M
Cash Acquisitions-401.28M-33.00K-84.49M
Sale (Purchase) of Intangibles-5.47M-20.49M-717.00K-9.64M-7.58M-21.08M
Investing Cash Flow-21.94M-34.32M-404.72M-18.51M-15.74M-105.48M
Long-Term Debt Issued641.25M310.03M
Long-Term Debt Repaid-10.16M-296.03M-3.00M-3.00M-211.01M
Total Debt Repaid-14.22M-10.16M-296.03M-3.00M-3.00M-211.01M
Net Debt Issued (Repaid)-14.22M-10.16M345.22M-3.00M-3.00M99.02M
Issuance of Common Stock12.34M13.60M6.49M89.55M1.46M71.65M
Repurchase of Common Stock-22.22M-12.21M-10.96M-4.99M-1.96M-890.00K
Preferred Dividends Paid-344.00K-1.16M-1.62M-1.62M-1.62M-190.00K
Dividends Paid-344.00K-1.16M-1.62M-1.62M-1.62M-190.00K
Other Financing Activities-106.00K-26.00K-74.18M-12.50M
Financing Cash Flow-24.55M-9.94M264.94M67.44M-5.13M194.59M
Foreign Exchange Rate Adjustments-554.00K-233.00K-470.00K
Net Cash Flow142.41M140.73M-76.23M167.89M-52.07M92.43M
Free Cash Flow172.99M171.39M47.78M110.09M-40.08M765.00K
Free Cash Flow Margin17.68%19.40%7.78%22.61%-12.67%0.35%
Free Cash Flow Per Share7.858.072.476.05-2.460.06
Levered Free Cash Flow132.21M119.42M42.67M114.36M-38.70M-28.62M
Unlevered Free Cash Flow151.52M139.53M63.38M136.26M-20.94M-21.16M
Cash Interest Paid25.31M26.93M24.38M31.43M21.48M9.71M
Cash Income Tax Paid14.14M17.67M19.06M1.23M288.00K10.37M
Change in Working Capital-37.91M-7.12M-11.19M24.86M-51.30M-84.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.54B1.65B1.08B1.05B655.90M771.45M
Enterprise Value1.79B2.01B1.58B1.18B913.29M966.43M
Last Close Price72.0078.9455.2855.1440.2346.08
PE Ratio15.8623.5068.00
Forward PE7.8610.0310.7214.0414.7912.86
PS Ratio1.581.871.762.162.073.57
PB Ratio2.583.052.522.301.942.15
P/TBV Ratio18.185.3819.3964.94
P/FCF Ratio8.929.6322.599.561,008.43
P/OCF Ratio8.148.9116.868.85232.22
PEG Ratio1.970.400.400.401.111.02
EV/Sales Ratio1.832.282.582.412.894.47
EV/EBITDA Ratio8.5611.5015.5710.7526.9350.64
EV/EBIT Ratio14.5024.1246.6823.73
EV/FCF Ratio10.3611.7333.1310.671,263.31
Debt / Equity Ratio1.051.161.460.620.850.80
Debt / EBITDA Ratio2.933.526.142.618.2615.06
Debt / FCF Ratio3.623.6713.062.60375.65
Net Debt / Equity Ratio0.420.621.100.140.710.52
Net Debt / EBITDA Ratio1.191.914.650.597.079.80
Net Debt / FCF Ratio1.441.959.900.59-5.98244.54
Asset Turnover0.690.650.560.580.410.35
Inventory Turnover2.752.441.911.681.481.41
Quick Ratio2.302.071.922.632.152.61
Current Ratio2.912.712.723.573.463.68
Return on Equity (ROE)20.46%16.16%-4.18%4.72%-13.74%-15.37%
Return on Assets (ROA)5.45%3.82%1.94%3.72%-2.10%-2.86%
Return on Invested Capital (ROIC)10.96%7.67%4.76%8.51%-4.58%-6.04%
Return on Capital Employed (ROCE)10.20%7.20%3.10%6.50%-3.90%-4.10%
Earnings Yield6.31%4.75%-1.72%1.79%-7.30%-5.52%
FCF Yield11.21%10.39%4.43%10.46%-6.11%0.10%
Payout Ratio1.48%8.65%
Buyback Yield / Dilution-12.56%-9.89%-6.18%-11.89%-29.09%-5.28%